Chrysea

Início / Chrysea

Categoria:

Outubro 7, 2025

Associados | Chrysea

Biosynthetic Blood Breakthrough: Chrysea and KaloCyte Enter into Exclusive Alliance to Transform Medical Emergency Care

– Chrysea and KaloCyte have entered into an exclusive license agreement, forging a global partnership that...

Julho 23, 2025

Associados | Chrysea

Chrysea presents additional study results on Spermidine Dietary Intake, BMI and Obesity at Benjamin Frankin Lafayette Seminar (BFLS), and significant association with reduced Cardiovascular risk markers at Gordon Research Conference (GRC)

– At BFLS, significant associations reported in a large representative cohort of 8965 Americans between higher...

Abril 16, 2025

Associados | Chrysea

Chrysea Unveils Groundbreaking Findings on Spermidine Dietary Intake and Cardiovascular Health at American Physiological Society (APS) Summit

– For the first time epidemiology study results define normal dietary intake norms and wide range in...

Junho 19, 2024

Associados | Chrysea

Chrysea Announces the Launch of Sprevive®: A Breakthrough in the Longevity Interventions Field

• Launching of first pure spermidine formulation with GRAS panel endorsement.• Scientifically backed by human...

Fevereiro 19, 2024

Associados | Chrysea

Chrysea and Chalmers University Partner for Development of Benzylisoquinoline Alkaloids for Human and Animal Healthcare

Researchers at Chalmers University of technology have developed an innovative yeast-based platform for producing Benzylisoquinoline...

Fevereiro 14, 2024

Associados | Chrysea | Rodon Biologics

Chrysea Acquires Rodon Biologics to Strengthen Capabilities in Synthetic Biology and Biopharmaceutical Products Development

Chrysea acquires operational capability, skills and know-how, to drive capital-efficiency. Chrysea accesses a highly-seasoned team...